Form 4: SeaStar Medical Director John Neuman Acquires 8,000 Restricted Stock Units

Director John Neuman of SeaStar Medical Holding Corp acquired 8,000 restricted stock units on November 13, 2024.

Summary

• John Neuman, a director at SeaStar Medical Holding Corp, acquired 8,000 restricted stock units (RSUs) on November 13, 2024.
• These RSUs represent a contingent right to receive one share of ICU common stock each.
• The RSUs will vest in equal installments over three years, specifically on the first, second, and third anniversaries of June 4, 2024.

Sentiment

Score: 7

Explanation: The acquisition of RSUs by a director is generally a positive sign, indicating confidence in the company's future. However, it's a routine transaction and not a major event.

Positives

• The acquisition of RSUs by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The vesting of the RSUs over the next three years suggests a long-term alignment of the director's interests with the company's performance.

Industry Context

This type of equity compensation is common for directors and executives in publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Granting restricted stock units to directors is a standard practice in the industry to incentivize performance and align interests with shareholders.
• The vesting schedule of three years is also a common practice to ensure long-term commitment from the director.
• Companies like Medtronic and Boston Scientific also use similar equity compensation strategies for their board members.

Stakeholder Impact

• The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

Restricted Stock Units, RSU, Director, SeaStar Medical, ICU, Stock Acquisition, Equity Compensation